EE93 Effects on Health and Costs of Delayed Implementation of the Oncotype DX® Test for Eligible Breast Cancer Patients
| Autor: | Appelberg, K 1, Wilking, N 2, LÅ, Levin 1 |
|---|---|
| Zdroj: | In Value in Health December 2024 27(12) Supplement:S72-S72 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect